Safety-Related Labeling Changes

Bleeding , No interaction studies evaluating use of caplacizumab with anticoagulants, antiplatelets, and thrombolytics

Trade Name

Cablivi

Updated Section

4.4 Special Warnings and Special Precautions for Use 4.5. Interactions with other medicinal products

Month

Mar,2023